GlassScriptPhysician profile
Charlene Lo Rohm
NPI 1922462241
$67,368.52
in general payments reported to CMS, 2019-2025
17 companies · $3,387 in 2025
The $3,387 reported for 2025 was more than what 77% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $137 · 2022: $146 · 2023: $1,888 · 2024: $62K · 2025: $3,387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $54K · Food and Beverage: $7,104 · Travel and Lodging: $5,742 · Education: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $54,000.00 |
| Food and Beverage | $7,104.30 |
| Travel and Lodging | $5,741.76 |
| Education | $239.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $56,149.70 | 2021-2025 | Mitraclip, Diamondback Coronary, Hi-Torque Balance |
| Edwards Lifesciences Corporation | $4,812.03 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Evoque |
| Medtronic, INC. | $2,146.42 | 2023-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Boston Scientific Corporation | $1,085.79 | 2023-2025 | Avvigo Guidance System, Mamba, Watchman Flx |
| Terumo Medical Corporation | $1,017.21 | 2023-2024 | Glidesheath Slender |
| Penumbra, INC. | $680.04 | 2023-2024 | Indigo System |
| Shockwave Medical, INC | $438.95 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $261.77 | 2023-2025 | Impella |
| Inari Medical, INC. | $167.51 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Heartflow, INC. | $145.83 | 2022 | |
| Cardiva Medical, INC. | $126.53 | 2024-2025 | Savvywire, Cardiva Vascade 6/7f Vcs |
| Chiesi USA, INC. | $123.42 | 2023 | Kengreal |
| Cathworks, INC. | $84.12 | 2023 | Ffrangio |
| Angiodynamics, INC. | $49.71 | 2024 | Angiovac |
| Pfizer INC. | $40.03 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $21.22 | 2025 | Verquvo |
| Teleflex LLC | $18.24 | 2025 | Trapliner |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charlene Rohm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.